Tango Therapeutics Inc is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNGX is expected to report earnings to fall 1.43% to -34 cents per share on November 05
Q3'25
Est.
$-0.34
Q2'25
Est.
$-0.35
Q1'25
Est.
$-0.36
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.10
The last earnings report on August 05 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 267.60K shares outstanding, the current market capitalization sits at 749.00M.